Today, we pause to remember the brave men and women who made the ultimate sacrifice for our country. We are eternally grateful for their service and sacrifice, and we honor their legacy.

ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio. Read the press release: globenewswire.com/news-release/2… $RSLS #MedTech #Healthcare

This week, Reshape announced EU MRR and UKCA certification for its full European and UK product portfolio, well ahead of the 2027 deadline. ICYMI, read the announcement: globenewswire.com/news-release/2… #Medtech #Healthcare

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets. Read more: reshapelifesciences.gcs-web.com/news-releases/… $RSLS #Healthcare #MedTech #VeteransAdministration

ReShape is proud to partner with Recon Supply to deliver STIMEL-03 and Lap-Band® 2.0 FLEX across VA and DoD #healthcare systems. Together, these technologies reflect our commitment to delivering high-impact, clinically proven solutions. reshapelifesciences.gcs-web.com/news-releases/… $RSLS

ReShape Lifesciences® is pleased to announce that it has been granted a key international patent in Australia for its proprietary diabetes #neuromodulation technology. Read the press release: reshapelifesciences.gcs-web.com/news-releases/… $RSLS #Healthcare #MedTech

ReShape Lifesciences® announces strategic cost reductions and provides an update on the merger agreement with Vyome Therapeutics and asset purchase agreement with Biorad Medisys. Read the press release: reshapelifesciences.gcs-web.com/news-releases/…

"The granting of this Australian patent is a major milestone that strengthens our international IP position," said CEO Paul F. Hickey. Patent protection until 2039. Read more: reshapelifesciences.gcs-web.com/news-releases/… #Healthcare #Type2Diabetes

ReShape Lifesciences® granted US patent related to an intragastric balloon system. The patent covers a swallowable capsule with a self-sealing fill valve and a degradable release valve Read press release reshapelifesciences.gcs-web.com/news-releases/… $RSLS #MedTech #Healthcare #IntragastricBalloon

Type 2 diabetes remains a global health challenge despite numerous interventions. "Our Diabetes Neuromodulation system offers a novel approach by using targeted bioelectronic modulation," said Dr. Jonathan Waataja. Read more reshapelifesciences.gcs-web.com/news-releases/… #Type2Diabetes #Neuromodulation

ReShape granted US Patent 12,350,179, entitled Intragastric Device Patent covers claims for an #intragastricballoon a swallowable capsule with self-sealing fill valve and degradable release valve The patent will provide protection into January 2031 Details bit.ly/4lC4R7M

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025. Read the press release: bit.ly/3IGaZxC $RSLS

ReShape Lifesciences® to host inaugural Lap-Band® Surgeon Summit, August 1-3, 2025, in Nashville, TN. Read the press release: reshapelifesciences.gcs-web.com/news-releases/… $RSLS #LapBand #WeightLoss #BariatricSurgeons

ReShape Lifesciences® will host the inaugural LapBand Surgeon Summit Aug 1–3 in Nashville, TN. The event will unite bariatric surgeons to support clinical collaboration around the Lap-Band® Program. Read more via The Clinical Trial Vanguard: bit.ly/4ocwyWU $RSLS #LapBand

ReShape’s inaugural Lap-Band® Surgeon Summit is taking place August 1-3, 2025, in Nashville, TN. We are looking forward to bringing together leading bariatric surgeons, underscoring our continued commitment to growing the Lap-Band® franchise. bit.ly/473VKsj $RSLS

The Lap-Band® Surgeon Summit begins today in Nashville. ReShape Lifesciences® will host bariatric surgeons for sessions on Lap-Band® 2.0 FLEX, GLP-1s, and patient engagement strategies. bit.ly/473VKsj $RSLS #LapBand #BariatricSurgeons #GLP1 #WeightLoss

Vyome announces new board of directors and is expected to take control of ReShape's public entity this Friday, August 15. $RSLS will be renamed Vyome Holdings, Inc. post-closing and trade under the ticker symbol $HIND. Read the press release: bit.ly/4oyJZAB

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as $HIND on Friday, August 15. Read the press release: bit.ly/45eU522 $RSLS

A new chapter begins! Today, Medtimo launches as a new subsidiary of Biorad Medisys Pvt. Ltd., signaling a transformative era for the company to meet the rising demand in both obesity treatment and stroke recovery. Read the press release: bit.ly/481Rs5j #Healthcare #MedTech

Medtimo Files Patent Infringement Complaint Against Allurion Technologies. As the cornerstone of our business, we have a long-standing commitment to developing and protecting our IP. bit.ly/3WesqbX